Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Filings indexed 146 across all filing types
Latest filing 2024-01-29 Earnings Release
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from Chong Kun Dang Bio regarding a significant change (over 30%) in sales or profit/loss structure. It provides preliminary financial data (revenue, operating profit, net income) for the fiscal year compared to the previous year. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for companies to announce material changes in financial performance before the final audit report is published. It fits the definition of an Earnings Release (ER) as it provides the initial announcement of financial results and key highlights. FY 2023
2024-01-29 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Chong Kun Dang Bio regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the submission of a Phase 3 clinical trial application to the Chinese NMPA for a botulinum toxin product. As this is a formal regulatory disclosure of a significant business event that does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2023-12-20 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Chong Kun Dang Bio' (종근당바이오) covering the period from 2023.01.01 to 2023.09.30. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Chong Kun Dang Bio, detailing quarterly financial performance (revenue, operating profit, net income) for the third quarter of 2023. It provides key financial highlights and is clearly an initial announcement of financial results rather than a full report or a report publication announcement. This fits the definition of an Earnings Release (ER). Q3 2023
2023-10-27 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '종근당바이오' covering the period from January 1, 2023, to June 30, 2023. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Chong Kun Dang Bio, detailing quarterly financial highlights such as revenue, operating profit, and net income. It is a short, structured announcement of financial results rather than a full report, fitting the definition of an Earnings Release (ER). Q2 2023
2023-07-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.